Webinar Date/Time: September 12, 2024 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST
An Improved Chlorhexidine Digluconate Impurity Separation Demonstrating Batch Reproducibility.
Register Free: https://www.chromatographyonline.com/lcgc_w/impact
Event Overview:
Chlorhexidine is a disinfectant and antiseptic widely used for skin disinfection prior to surgery, cleaning wounds, and treating oral infections. The current European Pharmacopeia chlorhexidine digluconate monograph has proved problematic. In this webinar, the proposed draft monograph is evaluated, considering multiple batches of HPLC columns, as well as the impact of system dwell volume on the overall performance and robustness of the monograph method.
Key Learning Objectives:
Who Should Attend:
Speaker:
Amra Perva
Doctor
University of Maribor, Faculty of Chemistry and Chemical Engineering
Amra Perva is employed as a research fellow at the faculty of chemistry and chemical engineering at the University of Maribor (Slovenia). She received a master’s degree with a thesis on the isolation of active ingredients from chile pepper and green tea by high pressure extractions. She moved to the analytical department in 2007 after obtaining her PhD in chemical engineering with a thesis on phase equilibria for designing a high pressure micronisation process for vanillins and cocoa butter. As the project lead in a GMP certified contract research organization (Group for Separation Analysis), she has more than a decade of experience working with pharmaceutical companies in the field of LC and GC method development, validation, stability and release testing for drug substances and drug products. She is responsible for delivering results obtained in compliance with monographs for assay and related substances.
Register Free: https://www.chromatographyonline.com/lcgc_w/impact
Pharmaceutical excipients, such as polyethylene glycol-based polymers, must be tested for the presence of ethylene oxide (EtO) and 1,4-dioxane as part of a safety assessment, according to USP Chapter <228>.
AOAC International Awarded NIST Grant for Developing Drug Testing Standards
October 31st 2024The grant will be part of a new collaborative scientific initiative to address the need for standards that define the desired performance of lateral flow immunoassay test strips to detect illicit drugs in tablets and powders.